Cite
Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis.
MLA
Zumla, Alimuddin, et al. “Potential of Immunomodulatory Agents as Adjunct Host-Directed Therapies for Multidrug-Resistant Tuberculosis.” BMC Medicine, vol. 14, June 2016, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s12916-016-0635-1.
APA
Zumla, A., Rao, M., Dodoo, E., & Maeurer, M. (2016). Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis. BMC Medicine, 14, 1–12. https://doi.org/10.1186/s12916-016-0635-1
Chicago
Zumla, Alimuddin, Martin Rao, Ernest Dodoo, and Markus Maeurer. 2016. “Potential of Immunomodulatory Agents as Adjunct Host-Directed Therapies for Multidrug-Resistant Tuberculosis.” BMC Medicine 14 (June): 1–12. doi:10.1186/s12916-016-0635-1.